335 related articles for article (PubMed ID: 24116930)
1. The structural role of receptor tyrosine sulfation in chemokine recognition.
Ludeman JP; Stone MJ
Br J Pharmacol; 2014 Mar; 171(5):1167-79. PubMed ID: 24116930
[TBL] [Abstract][Full Text] [Related]
2. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
Stone MJ; Payne RJ
Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.
Zhu JZ; Millard CJ; Ludeman JP; Simpson LS; Clayton DJ; Payne RJ; Widlanski TS; Stone MJ
Biochemistry; 2011 Mar; 50(9):1524-34. PubMed ID: 21235238
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.
Seibert C; Sanfiz A; Sakmar TP; Veldkamp CT
Methods Enzymol; 2016; 570():357-88. PubMed ID: 26921955
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.
Liu J; Louie S; Hsu W; Yu KM; Nicholas HB; Rosenquist GL
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):738-43. PubMed ID: 18218997
[TBL] [Abstract][Full Text] [Related]
6. Semisynthesis of an evasin from tick saliva reveals a critical role of tyrosine sulfation for chemokine binding and inhibition.
Franck C; Foster SR; Johansen-Leete J; Chowdhury S; Cielesh M; Bhusal RP; Mackay JP; Larance M; Stone MJ; Payne RJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12657-12664. PubMed ID: 32461364
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.
Hewit KD; Fraser A; Nibbs RJ; Graham GJ
J Biol Chem; 2014 May; 289(18):12330-42. PubMed ID: 24644289
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region of CCR3 bound to CCL11/eotaxin-1.
Millard CJ; Ludeman JP; Canals M; Bridgford JL; Hinds MG; Clayton DJ; Christopoulos A; Payne RJ; Stone MJ
Structure; 2014 Nov; 22(11):1571-81. PubMed ID: 25450766
[TBL] [Abstract][Full Text] [Related]
9. Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.
Simpson LS; Zhu JZ; Widlanski TS; Stone MJ
Chem Biol; 2009 Feb; 16(2):153-61. PubMed ID: 19246006
[TBL] [Abstract][Full Text] [Related]
10. CCR7 Sulfotyrosine Enhances CCL21 Binding.
Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
[TBL] [Abstract][Full Text] [Related]
11. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
Colvin RA; Campanella GS; Manice LA; Luster AD
Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
[TBL] [Abstract][Full Text] [Related]
12. Phosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2).
Ludeman JP; Nazari-Robati M; Wilkinson BL; Huang C; Payne RJ; Stone MJ
Org Biomol Chem; 2015 Feb; 13(7):2162-9. PubMed ID: 25536525
[TBL] [Abstract][Full Text] [Related]
13. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
[TBL] [Abstract][Full Text] [Related]
14. Chapter 7. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors.
Choe H; Farzan M
Methods Enzymol; 2009; 461():147-70. PubMed ID: 19480918
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).
Tan JHY; Ludeman JP; Wedderburn J; Canals M; Hall P; Butler SJ; Taleski D; Christopoulos A; Hickey MJ; Payne RJ; Stone MJ
J Biol Chem; 2013 Apr; 288(14):10024-10034. PubMed ID: 23408426
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region.
Preobrazhensky AA; Dragan S; Kawano T; Gavrilin MA; Gulina IV; Chakravarty L; Kolattukudy PE
J Immunol; 2000 Nov; 165(9):5295-303. PubMed ID: 11046064
[TBL] [Abstract][Full Text] [Related]
17. Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors.
Szpakowska M; Fievez V; Arumugan K; van Nuland N; Schmit JC; Chevigné A
Biochem Pharmacol; 2012 Nov; 84(10):1366-80. PubMed ID: 22935450
[TBL] [Abstract][Full Text] [Related]
18. CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties.
Scurci I; Akondi KB; Pinheiro I; Paolini-Bertrand M; Borgeat A; Cerini F; Hartley O
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129753. PubMed ID: 32991968
[TBL] [Abstract][Full Text] [Related]
19. Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.
Ziarek JJ; Getschman AE; Butler SJ; Taleski D; Stephens B; Kufareva I; Handel TM; Payne RJ; Volkman BF
ACS Chem Biol; 2013 Sep; 8(9):1955-63. PubMed ID: 23802178
[TBL] [Abstract][Full Text] [Related]
20. Interaction of chemokines with their receptors--from initial chemokine binding to receptor activating steps.
Thiele S; Rosenkilde MM
Curr Med Chem; 2014; 21(31):3594-614. PubMed ID: 25039782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
